Our People

The MedAlliance team is diversified in background, knowledge, and culture to provide the broadest possible perspective. They bring together experience from different types of companies, ranging from start-ups to well established multinationals.

Our experts have a recognized track record of success in the creation, development and global commercialization of drug-eluting stents, balloons, polymers and drugs. They are passionate people, driven by innovation, with a clear focus on patient benefit and proving this benefit with clinical-based evidence.

The majority of the company’s R&D and manufacturing is conducted in-house, giving it more flexibility and agility over larger rivals and allowing it to retain greater control over its proprietary technology.

Board of Directors

Jeffrey B. Jump

Chairman and CEO

Jeffrey B. Jump

Jeffrey B. Jump

Chairman and CEO

Jeff has nearly 40 years’ experience of the international medical devices industry, 15 years of which have been at Board level. He is the former CEO of SGX publicly listed company Biosensors where he spent 13 years, which during this time grew from a start-up to become the fourth largest supplier of cardiac stents in the world. In addition to President and CEO he served as a Board Director and Chairman of Biosensors Europe.Jeff has also been a Non-Executive Director of various medical device companies including Symetis (sold to Boston Scientific), PneumRx (sold to BTG), Maya (sold to Covidien), Benechill, Anecova, Veryan and ARTS. He is currently serving as an Independent Board Director for Impulse Dynamics and Chairman of both Combioxin S.A. and Aleva Neuro S.A.


Simos Kedikoglou

Board Director

Simos Kedikoglou

Simos Kedikoglou

Board Director

Simos is currently CEO of Impulse Dynamics, a medical device manufacturer of a heart failure implantable device with a presence in the US, Europe and Asia.  He was previously a Corporate Vice President of Business Development for Boston Scientific.  In this capacity, he sourced, negotiated and closed investments and strategic alliances in the US, Japan and Emerging Markets. Prior to this, he was an Associate Partner with McKinsey & Company specializing in financial investments in medical technology and pharmaceutical companies for private equity and corporate clients.


Sam Murphy

Board Director

Sam Murphy

Sam Murphy

Board Director

Sam currently serves as VP and Head of International Business Development for Salubris Pharmaceuticals and its US subsidiary SalubrisBio.  Prior to joining Salubris, Sam worked for ten years in strategy consulting and transaction advisory services across several global firms including IMS (now IQVIA) and Simon-Kucher & Partners.  Sam’s commercial strategy engagements encompassed 18 of the top 25 pharmaceutical companies, as well as numerous small and mid-sized biotech companies, with an emphasis on pricing and market access. He has also supported early-stage financing for emerging pharma/biotech companies.  Sam is currently a Board Member of GO Therapeutics and Viracta Therapeutics, as well as a Board Observer at Mercator Medsystems.


Management Team

Jeffrey B. Jump

Chairman and CEO

Jeffrey B. Jump

Jeffrey B. Jump

Chairman and CEO

Jeff has nearly 40 years’ experience of the international medical devices industry, 15 years of which have been at Board level. He is the former CEO of SGX publicly listed company Biosensors where he spent 13 years, which during this time grew from a start-up to become the fourth largest supplier of cardiac stents in the world. In addition to President and CEO he served as a Board Director and Chairman of Biosensors Europe.Jeff has also been a Non-Executive Director of various medical device companies including Symetis (sold to Boston Scientific), PneumRx (sold to BTG), Maya (sold to Covidien), Benechill, Anecova, Veryan and ARTS. He is currently serving as an Independent Board Director for Impulse Dynamics and Chairman of both Combioxin S.A. and Aleva Neuro S.A.


John Shulze

Chief Technology Officer

John Shulze

John Shulze

Chief Technology Officer

John has over 40 years’ experience in the medical device industry, including positions held in product development, manufacturing, sales and marketing management with Spacelabs, Gould Medical/Spectramed and Bird Respiratory Corporation.  John co-founded Albion Instruments, a successful startup that developed laser instruments for precision measurement of depth of anesthesia and respiration/gas exchange for patients undergoing general anesthesia.  At Bird Corporation, he supervised development of a ventilator which is now the system of choice for life saving rescue procedures involving premature newborns. At Spectramed he successfully designed and introduced thermodilution catheter technology and a line of disposable blood pressure transducers.  John was a co-founder of Biosensors International, a successful public company for whom he designed the first drug-eluting stents with biodegradable polymer coatings. Biosensors grew to over $200M sales/1600 employees during his tenure as CTO. A founder of MedAlliance, John assembled the initial engineering team and has been the primary architect of the company’s innovative SELUTION™ SLR drug-coated balloon technology.


Dominique Vaney

Chief Financial Officer

Dominique Vaney

Dominique Vaney

Chief Financial Officer

Dominique has over 20 years’ experience in accounting and administration, both in industry such as BTG and in the medical field, especially in start-ups such as Wallsten Medical, Anecova and Xitact, where he served both as Finance & Administration Manager and CFO. At Xitact, Dominique was also Secretary of the Board and actively participated in the trade sale of the company to Mentice AB, where he stayed for a further two years before joining MedAlliance. Dominique was appointed CFO of MedAlliance in 2009.


Susanne Meis

Vice President Medical Affairs

Susanne Meis

Susanne Meis

Vice President Medical Affairs

Susanne has over 25 years’ experience in the Medical Device industry. She joined MedAlliance in 2016 as VP Medical Affairs and is responsible for Clinical, Medical Affairs and Marketing activities. Susanne brings a wealth of experience from her previous roles in the medical device industry and an ability to adapt to challenging business settings. Prior to joining MedAlliance she was Director Medical Communication at Biosensors, and has held several Marketing positions at Abbott Vascular, JOMED, Boston Scientific and 3M.


Mark Steckel

Vice President R&D,RA,QA

Mark Steckel

Mark Steckel

Vice President R&D,RA,QA

Mark has more than 30 years of medical device experience, holding senior roles in Product Development, Regulatory and Clinical Research.  He has in-depth experience bringing complex and novel Class III devices from concept through to commercialization including absorbable polymer implants and device-drug combination products.  He was most recently VP R&D Clinical Regulatory for Terumo in Europe. Some of his previous positions include Senior Research Fellow in Drug Delivery at Boston Scientific, Director R&D at Biotronik, Chief Technology Officer at Capella, and Director R&D at JNJ Mitek.


Scott Olson

Vice President Manufacturing

Scott Olson

Scott Olson

Vice President Manufacturing

Scott has over 35 years’ experience of the international medical devices industry, 25 years of which have been in senior management roles. He has successfully led several start-up companies, having been responsible for significant growth of each. This has included development from R&D to full manufacturing, with Quality Systems to facilitate commercialization of key products.  Scott is Founder-VP Operations & Finance at Hummingbird Medical and was previously COO and Executive VP Operations at Biosensors. He was also a Senior Manager within the Cardiovascular Division of both Sorin Biomedical and Shiley.